The year 2026 represents a massive leap forward in biotechnology, where the traditional "trial and error" method of protein synthesis has been replaced by predictive intelligence. A core driver in the recombinant proteins market is the widespread adoption of AI algorithms that can model complex protein structures and folding patterns with near-perfect accuracy before a single cell is cultured....